10-Q
Quarterly Report
AMERICAN HEALTHCARE REIT, INC.
AHR
NYSE
CIK: 1632970
File #: 001-41951
Balance Sheet
54 line items · 2 periods
XBRL
| Item | Mar 31, 2025 | Dec 31, 2024 |
|---|---|---|
ASSETS | ||
Real estate investments, net | 3,337,008,000 | 3,366,648,000 |
United States | 3,294,401,000 | 3,324,982,000 |
International | 42,607,000 | 41,666,000 |
Debt security investment, net | 91,698,000 | 91,264,000 |
Cash and cash equivalents | 86,064,000 | 76,702,000 |
Restricted cash | 41,389,000 | 46,599,000 |
Accounts and other receivables, net | 222,657,000 | 211,104,000 |
Identified intangible assets, net | 156,426,000 | 161,473,000 |
Goodwill | 234,942,000 | 234,942,000 |
Integrated senior health campuses | 168,177,000 | 168,177,000 |
OM | 47,812,000 | 47,812,000 |
Triple-net leased properties | 18,953,000 | 18,953,000 |
Operating lease right-of-use assets, net | 153,349,000 | 163,987,000 |
2025 Acquisitions | 6,374,000 | — |
Other assets, net | 140,518,000 | 135,338,000 |
Total assets | 4,464,051,000 | 4,488,057,000 |
Integrated senior health campuses | 2,214,378,000 | 2,202,582,000 |
OM | 1,110,996,000 | 1,140,785,000 |
SHOP | 714,255,000 | 729,466,000 |
Triple-net leased properties | 400,966,000 | 401,782,000 |
Other | 23,456,000 | 13,442,000 |
LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND EQUITY | ||
Liabilities: | ||
Mortgage loans payable, net | 1,000,489,000 | 982,071,000 |
Lines of credit and term loan, net | 642,567,000 | 688,534,000 |
Line of Credit - 2024 Credit Agreement | 643,000,000 | 689,000,000 |
Revolving Credit Facility - 2019 Trilogy Credit Facility | — | 32,000 |
Accounts payable and accrued liabilities | 272,274,000 | 258,324,000 |
Identified intangible liabilities, net | 2,810,000 | 3,001,000 |
Below-Market Lease | 2,810,000 | 3,001,000 |
Financing obligations | 34,599,000 | 34,870,000 |
Operating lease liabilities | 153,585,000 | 165,239,000 |
2025 Acquisitions | 7,445,000 | — |
Security deposits, prepaid rent and other liabilities | 53,019,000 | 51,856,000 |
Total liabilities | 2,159,343,000 | 2,183,895,000 |
Redeemable noncontrolling interests | 220,000 | 220,000 |
Equity: | ||
Stockholders’ equity: | ||
Preferred Stock | 0 | 0 |
Common Stock | 1,583,000 | 1,564,000 |
Additional paid-in capital | 3,768,030,000 | 3,720,268,000 |
Accumulated deficit | (1,504,861,000) | (1,458,089,000) |
Accumulated other comprehensive loss | (2,336,000) | (2,512,000) |
Total stockholders’ equity | 2,262,416,000 | 2,261,231,000 |
Noncontrolling interests | 42,072,000 | 42,711,000 |
Total equity | 2,304,488,000 | 2,303,942,000 |
Common Stock - Common Stock | 1,583,000 | 1,564,000 |
Additional Paid-In Capital | 3,768,030,000 | 3,720,268,000 |
Accumulated Deficit | (1,504,861,000) | (1,458,089,000) |
Accumulated Other Comprehensive Loss | (2,336,000) | (2,512,000) |
Total Stockholders' Equity | 2,262,416,000 | 2,261,231,000 |
Noncontrolling Interests | 42,072,000 | 42,711,000 |
Total liabilities, redeemable noncontrolling interests and equity | 4,464,051,000 | 4,488,057,000 |